Tower Research Capital (TRC)’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8 Sell
3
-12,475
-100% -$33.3K ﹤0.01% 5231
2025
Q1
$42.3K Buy
12,478
+4,534
+57% +$15.4K ﹤0.01% 2340
2024
Q4
$32.7K Buy
7,944
+6,412
+419% +$26.4K ﹤0.01% 2841
2024
Q3
$3.82K Sell
1,532
-15,426
-91% -$38.4K ﹤0.01% 4767
2024
Q2
$44.8K Buy
16,958
+11,284
+199% +$29.8K ﹤0.01% 3189
2024
Q1
$11.7K Buy
5,674
+38
+0.7% +$78 ﹤0.01% 3541
2023
Q4
$10.1K Sell
5,636
-2,807
-33% -$5.05K ﹤0.01% 4286
2023
Q3
$11.6K Sell
8,443
-3,007
-26% -$4.12K ﹤0.01% 3979
2023
Q2
$15.7K Buy
11,450
+5,199
+83% +$7.12K ﹤0.01% 3593
2023
Q1
$15K Buy
6,251
+4,353
+229% +$10.4K ﹤0.01% 3780
2022
Q4
$4K Buy
1,898
+1,258
+197% +$2.65K ﹤0.01% 4998
2022
Q3
$1K Sell
640
-395
-38% -$617 ﹤0.01% 5762
2022
Q2
$3K Sell
1,035
-291
-22% -$843 ﹤0.01% 5365
2022
Q1
$5K Sell
1,326
-730
-36% -$2.75K ﹤0.01% 5039
2021
Q4
$9K Buy
+2,056
New +$9K ﹤0.01% 4683
2021
Q3
Sell
-643
Closed -$5K 5852
2021
Q2
$5K Buy
+643
New +$5K ﹤0.01% 4702
2021
Q1
Sell
-2,598
Closed -$40K 5466
2020
Q4
$40K Buy
2,598
+1,341
+107% +$20.6K ﹤0.01% 3319
2020
Q3
$21K Buy
+1,257
New +$21K ﹤0.01% 3848
2018
Q2
Sell
-16
Closed -$1K 3740
2018
Q1
$1K Sell
16
-68
-81% -$4.25K ﹤0.01% 3056
2017
Q4
$6K Sell
84
-227
-73% -$16.2K ﹤0.01% 2808
2017
Q3
$29K Buy
311
+267
+607% +$24.9K ﹤0.01% 2464
2017
Q2
$5K Sell
44
-123
-74% -$14K ﹤0.01% 1974
2017
Q1
$23K Buy
+167
New +$23K ﹤0.01% 1208
2016
Q4
Sell
-98
Closed -$24K 3944
2016
Q3
$24K Buy
98
+78
+390% +$19.1K ﹤0.01% 1505
2016
Q2
$17K Buy
+20
New +$17K ﹤0.01% 2370
2016
Q1
Sell
-7
Closed -$10K 4302
2015
Q4
$10K Buy
+7
New +$10K ﹤0.01% 2098
2015
Q3
Sell
-3
Closed -$7K 4184
2015
Q2
$7K Sell
3
-12
-80% -$28K ﹤0.01% 2987
2015
Q1
$27K Buy
+15
New +$27K ﹤0.01% 1991
2014
Q4
Sell
-1
Closed -$3K 4172
2014
Q3
$3K Buy
+1
New +$3K ﹤0.01% 3597